Immupharma PLC 2019 Annual General Meeting (6908D)

TIDMIMM

RNS Number : 6908D

Immupharma PLC

27 June 2019

27 JUNE 2019

ImmuPharma PLC

("ImmuPharma" or the "Company")

2019 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED

ImmuPharma PLC (LSE:IMM), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all resolutions were duly passed.

-Ends-

 
 
   For further information please contact: 
    ImmuPharma PLC (www.immupharma.com) 
     Tim McCarthy, Chairman                       + 44 (0) 207 152 4080 
    Dimitri Dimitriou, Chief Executive Officer 
    Lisa Baderoon, Head of Investor Relations     + 44 (0) 7721 413496 
    SPARK Advisory Partners Limited (NOMAD) 
     Neil Baldwin                                 +44 (0) 203 368 8974 
     Vassil Kirtchev 
 
     Stanford Capital Partners (Joint Broker) 
     Patrick Claridge, John Howes                 +44 (0) 203 815 8880 
 
     SI Capital (Joint Broker) 
     Nick Emerson                                 +44 (0) 1483 413500

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

AGMUBOURKVANUAR

(END) Dow Jones Newswires

June 27, 2019 08:38 ET (12:38 GMT)

Immupharma (LSE:IMM)
Historical Stock Chart
From Jun 2024 to Jul 2024